Table 1.
B-cell populations | B-cell surface phenotype | Signalling (anti-IgM) | Mouse | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mouse strain | Genetic Background | MZ | B1 | Recirc. | sIgM | MHC II | CD22 | Ca2+ | Prolif. | Apop. | Serum IgM | Td | Ti | AutoAb | Reference |
CD22−/− | mixed 129 × B6 (from 129 ES cells) | ↓ | ↑ | ↓ | ↓ | ↑ | n.a. | ↑ | ↓ | ↑ | ↑ | ← → | ↓ | Yes (1 of 3 lines) | 46, 133, 134 |
CD22−/− | B6, (from B6 ES cells) | ↓ | ← → | ↓ | ↓ | ↑ | n.a. | ↑ | ← → | ↑ | ↑ (> 5 mo) | ← → | ↓ | No | 30 |
CD22Δ1-2 | Backcrossed to B6 for 6 generations. | ↓ | ↑ | ↓ | ↓ | ↑ | ↓ | ← → | ↓ | n.d. | n.d. | n.d. | n.d. | n.d. | 55 |
CD22AA | ↓ | ↑ | ↓ | ↓ | ↑ | ↓ | ← → | ↓ | n.d. | n.d. | n.d. | n.d. | n.d. | 55 | |
CD22a.B6 | B6 (congenic with NZB CD22a allotype) | ← → | n.d. | n.d. | ↓ | ↑ | ↓ | ← → | ↓ | n.d. | n.d. | n.d. | n.d. | Yes (Coombs Ab) | 65 |
CD22 R130E | B6 | ↓ | ← → | ↓ | n.d. | n.d. | ← → | ↓ | n.d. | n.d. | ← → | ← → | ← → | n.d. | 39 |
CD22 ITIM mutant | B6 | ↓ | ← → | ↓ | n.d. | n.d. | ← → | ↑ | n.d. | n.d. | ↑ | ↑ | ← → | n.d. | 39 |
ST6Gal I−/− | Backcrossed to B6 for 6 generations from 129. | ↓ | ← → | ↓ | ↓ ↓ | ← → | ↓ | ↓ | ↓ | n.d. | ↓ | ↓ | ↓ | n.d. | 65, 135, 136 |
ST6Gal I−/− × CD22−/− | ↓ | ← → | ↓ | ↓ ↓ | n.d | n.a. | ↑ | ↓ | n.d. | n.d. | n.d. | n.d. | n.d. | 137 | |
SIAE−/− | mixed 129 × B6 (from 129 ES cells) | ↓ | n.d. | ↓ | ← → | n.d | ← → | ↑ | ↓ | ↑ | ↑ | ↓ | ↑ | Yes | 19 |
CMAH−/− | 2 lines: B6, mixed 129/B6 | ↓ | n.d. | ↓ | ← → | ← → | ← → | ↑ | ↑ | n.d. | ← → | ← → | ↑ | n.d. | 91, 138 |
Note: This an expanded and updated version of a summary table originally presented in a review by Smith et al (11). Td = T-dependent; Ti = T-independent; AutoAb = autoantibody; B6 = C57/BL6; sIgM = surface IgM; n.d = not determined; n.a. = not applicable.